Charming Medical FY26 turns to net loss of US$22,648; revenue drops 22.7% to US$4.81 million

• Charming Medical posted a net loss of US$22,648 for the year ended March 31, 2026, swinging from net income a year earlier.
• Revenue fell 22.7% to US$4.81 million, driven by a 24.4% drop in beauty, wellness and postpartum services to US$4.51 million.
• Operating loss was US$29,237, compared with operating income a year earlier, as professional fees jumped to US$782,448 on Nasdaq listing costs.
• Cash and cash equivalents rose to US$4.7 million, while operating cash flow turned to an outflow of US$1.22 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Charming Medical Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-083325), on July 30, 2026, and is solely responsible for the information contained therein.